Indeed, if circulating sNRP1 has already been proposed as a possible diagnostic biomarker for different diseases such as cervical cancer, cervical intraepithelial neoplasia, and hepatocellular carcinoma [36,39], to our knowledge here we explored for the first time the diagnostic power of circulating Sema3E. This evidence concerns the gene SEMA3E and hepatocellular carcinoma.